Dissolved and financials
CVR: 38003429
DKK 0
Gross profit
Net result: DKK 1,406
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 7 January 2021
CVR · view overview
No headcount reported
Director role ended: Claus Heiner Bang-Berthelsen
CVR · 23/10/2020
View the full event history
Idun Genomics IVS was a Danish company of the type Iværksætterselskab based in Allerød, founded in 2016. The company has been dissolved on 7 January 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 1,406. Equity in the 2018 report amounted to DKK 1,408.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/01/2018 – 31/12/2018 | 0 | 1 t. | 1 t. | 1 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Idun Genomics IVS is registered in the Danish CVR register with the status Dissolved and ceased on 7 January 2021.
The CVR number of Idun Genomics IVS is 38003429.
In 2018, Idun Genomics IVS reported a gross profit of DKK 0.
Idun Genomics IVS was founded on 12 September 2016.
Idun Genomics IVS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
Idun Genomics IVS was located at c/o Claus Heiner Bang-Berthelsen, Rosmosevej 8, 3450 Allerød.
Idun Genomics IVS was dissolved on January 7, 2021.
As of October 23, 2020, Mads Hartvig Clausen has left the board of directors of Idun Genomics IVS.
As of October 23, 2020, Claus Heiner Bang-Berthelsen has stepped down as chairman of Idun Genomics IVS.
As of October 23, 2020, Claus Heiner Bang-Berthelsen has stepped down as director of Idun Genomics IVS.
Idun Genomics IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 1,406.
As of December 6, 2018, Lasse Westergaard Folkersen has left the board of directors of Idun Genomics IVS.
Idun Genomics IVS has published its interim report for the period September 12, 2016 – December 31, 2017.
As of November 28, 2017, Mads Hartvig Clausen has joined the board of directors of Idun Genomics IVS.
As of November 28, 2017, Lasse Westergaard Folkersen has stepped down as director of Idun Genomics IVS.
As of November 28, 2016, Axel Rotwitt Bang-Berthelsen has left the board of directors of Idun Genomics IVS.
As of November 28, 2016, Claus Heiner Bang-Berthelsen is registered as chairman of Idun Genomics IVS.
As of November 28, 2016, Claus Heiner Bang-Berthelsen is registered as director of Idun Genomics IVS.
As of November 28, 2016, Axel Rotwitt Bang-Berthelsen has stepped down as director of Idun Genomics IVS.
As of September 12, 2016, Axel Rotwitt Bang-Berthelsen has joined the board of directors of Idun Genomics IVS.
As of September 12, 2016, Lasse Westergaard Folkersen has joined the board of directors of Idun Genomics IVS.
As of September 12, 2016, Axel Rotwitt Bang-Berthelsen is registered as director of Idun Genomics IVS.
As of September 12, 2016, Lasse Westergaard Folkersen is registered as director of Idun Genomics IVS.
Idun Genomics IVS was founded on September 12, 2016.
